Cargando…
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187493/ https://www.ncbi.nlm.nih.gov/pubmed/32345371 http://dx.doi.org/10.1186/s40035-020-00193-3 |
_version_ | 1783527187281870848 |
---|---|
author | Reichmann, Heinz Lees, Andrew Rocha, José-Francisco Magalhães, Diogo Soares-da-Silva, Patrício |
author_facet | Reichmann, Heinz Lees, Andrew Rocha, José-Francisco Magalhães, Diogo Soares-da-Silva, Patrício |
author_sort | Reichmann, Heinz |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7187493 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71874932020-04-30 Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study Reichmann, Heinz Lees, Andrew Rocha, José-Francisco Magalhães, Diogo Soares-da-Silva, Patrício Transl Neurodegener Correction BioMed Central 2020-04-28 /pmc/articles/PMC7187493/ /pubmed/32345371 http://dx.doi.org/10.1186/s40035-020-00193-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correction Reichmann, Heinz Lees, Andrew Rocha, José-Francisco Magalhães, Diogo Soares-da-Silva, Patrício Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study |
title | Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study |
title_full | Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study |
title_fullStr | Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study |
title_full_unstemmed | Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study |
title_short | Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study |
title_sort | correction to: effectiveness and safety of opicapone in parkinson’s disease patients with motor fluctuations: the optipark open-label study |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187493/ https://www.ncbi.nlm.nih.gov/pubmed/32345371 http://dx.doi.org/10.1186/s40035-020-00193-3 |
work_keys_str_mv | AT reichmannheinz correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy AT leesandrew correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy AT rochajosefrancisco correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy AT magalhaesdiogo correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy AT soaresdasilvapatricio correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy AT correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy |